Barium titanate nanoparticles: Highly cytocompatible dispersions in glycol-chitosan and doxorubicin complexes for cancer therapy

69Citations
Citations of this article
95Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the latest years, innovative nanomaterials have attracted a dramatic and exponentially increasing interest, in particular for their potential applications in the biomedical field. In this paper, we reported our findings on the cytocompatibility of barium titanate nanoparticles (BTNPs), an extremely interesting ceramic material. A rational and systematic study of BTNP cytocompatibility was performed, using a dispersion method based on a noncovalent binding to glycol-chitosan, which demonstrated the optimal cytocompatibility of this nanomaterial even at high concentration (100 μg/ml). Moreover, we showed that the efficiency of doxorubicin, a widely used chemotherapy drug, is highly enhanced following the complexation with BTNPs. Our results suggest that innovative ceramic nanomaterials such as BTNPs can be realistically exploited as alternative cellular nanovectors. © The Author(s) 2010.

Cite

CITATION STYLE

APA

Ciofani, G., Danti, S., D’Alessandro, D., Moscato, S., Petrini, M., & Menciassi, A. (2010). Barium titanate nanoparticles: Highly cytocompatible dispersions in glycol-chitosan and doxorubicin complexes for cancer therapy. Nanoscale Research Letters, 5(7), 1093–1101. https://doi.org/10.1007/s11671-010-9607-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free